InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: Biobillionair post# 16113

Wednesday, 10/09/2013 6:55:52 PM

Wednesday, October 09, 2013 6:55:52 PM

Post# of 426487
Thanks Bio for the info. The panel vote for Invokana was 10-5 on efficacy and 8-7 on safety due to raised concerns about cardiovascular risks. FDA still approved the drug. Guess what the panel votes for Vascepa, which improves various bio-markers and cardiovascular health, will be.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News